Related references
Note: Only part of the references are listed.Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease
Sagi Tamir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin
Christian Henninger et al.
PHARMACOLOGICAL RESEARCH (2015)
Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
Samira Lakhal-Littleton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Deferasirox effect on renal haemodynamic parameters in patients with transfusion-dependent β thalassaemia
Antonio Piga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Iron Toxicity in Hematopoietic Stem Cell Transplantation: Strike while the Iron Is Labile
Vinod Pullarkat
ACTA HAEMATOLOGICA (2014)
Mammalian Fe-S cluster biogenesis and its implication in disease
Lena K. Beilschmidt et al.
BIOCHIMIE (2014)
The regulation of iron transport
David M. Frazer et al.
BIOFACTORS (2014)
The liver: conductor of systemic iron balance
Delphine Meynard et al.
BLOOD (2014)
Molecular liaisons between erythropoiesis and iron metabolism
Leon Kautz et al.
BLOOD (2014)
Cardiac Involvement in Hemochromatosis
Vinay Gulati et al.
CARDIOLOGY IN REVIEW (2014)
Cardiac Mitochondria and Reactive Oxygen Species Generation
Yeong-Renn Chen et al.
CIRCULATION RESEARCH (2014)
mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload
Casey J. Brewer et al.
EXPERIMENTAL HEMATOLOGY (2014)
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
Hana Jansova et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Physiology and pathophysiology of iron in hemoglobin-associated diseases
Thomas D. Coates
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Antioxidant targeting by deferiprone in diseases related to oxidative damage
Christina N. Kontoghiorghe et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
Iron deficiency: an emerging therapeutic target in heart failure
Alain Cohen-Solal et al.
HEART (2014)
The Mismetallation of Enzymes during Oxidative Stress
James A. Imlay
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
Federica Maccarinelli et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Sex differences and steroid modulation of cardiac iron in a mouse model of iron overload
Casey Brewer et al.
TRANSLATIONAL RESEARCH (2014)
Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial
Amarah Shakoor et al.
BMJ OPEN (2014)
Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major
A. John Baksi et al.
FRONTIERS IN PHARMACOLOGY (2014)
Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
Alain Martelli et al.
FRONTIERS IN PHARMACOLOGY (2014)
The role of iron in anthracycline cardiotoxicity
Elena Gammella et al.
FRONTIERS IN PHARMACOLOGY (2014)
Labile iron in cells and body fluids: physiology, pathology, and pharmacology
Zvi Ioav Cabantchik
FRONTIERS IN PHARMACOLOGY (2014)
Optimal method for early detection of cardiac disorders in thalassemia major patients: magnetic resonance imaging or echocardiography?
Farideh Moussavi et al.
BLOOD RESEARCH (2014)
Amlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial
Juliano Lara Fernandes et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
Martin Sterba et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Impact of Hemochromatosis Gene Mutations on Cardiac Status in Doxorubicin-Treated Survivors of Childhood High-Risk Leukemia
Steven E. Lipshultz et al.
CANCER (2013)
Thromboxane A2 Mediates Iron-Overload Cardiomyopathy in Mice Through Calcineurin-Nuclear Factor of Activated T Cells Signaling Pathway
Heng Lin et al.
CIRCULATION JOURNAL (2013)
Cardiomyocyte ultrastructural damage in β-thalassaemic mice
Chanita Sanyear et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Complementary RNA and Protein Profiling Identifies Iron as a Key Regulator of Mitochondrial Biogenesis
Jarred W. Rensvold et al.
CELL REPORTS (2013)
Prooxidant Mechanisms in Iron Overload Cardiomyopathy
Ching-Feng Cheng et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Regional siderosis: a new challenge for iron chelation therapy
Zvi Ioav Cabantchik et al.
FRONTIERS IN PHARMACOLOGY (2013)
Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: Implications for treatments
Eugenio Mocchegiani et al.
AGEING RESEARCH REVIEWS (2012)
Hepatic Iron Deposition Does Not Predict Extrahepatic Iron Loading in Mouse Models of Hereditary Hemochromatosis
V. Nathan Subramaniam et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Mechanisms of Mammalian Iron Homeostasis
Kostas Pantopoulos et al.
BIOCHEMISTRY (2012)
Non-transferrin bound iron: A key role in iron overload and iron toxicity
Pierre Brissot et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Hepcidin and iron homeostasis
Tomas Ganz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Emilio Ramos et al.
BLOOD (2012)
Design of iron chelators with therapeutic application
Tao Zhou et al.
DALTON TRANSACTIONS (2012)
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice
Sirinart Kumfu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Lipocalin-2 Induces Cardiomyocyte Apoptosis by Increasing Intracellular Iron Accumulation
Guoxiong Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Iron Overload in Human Disease
Robert E. Fleming et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cardiac Protection by Preconditioning Is Generated via an Iron-Signal Created by Proteasomal Degradation of Iron Proteins
Baruch E. Bulvik et al.
PLOS ONE (2012)
Might the beneficial effects of statin drugs be related to their action on iron metabolism?
L. Mascitelli et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2012)
被撤回的出版物: Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity (Retracted article. See MAY, 2020)
R. D. Spagnuolo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Iron Overload Decreases CaV1.3-Dependent L-Type Ca2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation
Robert A. Rose et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2011)
Iron as a target of chemoprevention for longevity in humans
Shinya Toyokuni
FREE RADICAL RESEARCH (2011)
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
Alessia Pepe et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Iron-Induced Cardiac Damage: Role of Apoptosis and Deferasirox Intervention
Yeling Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Giada Sebastiani et al.
METALLOMICS (2011)
Iron-Chelating Therapy for Transfusional Iron Overload
Gary M. Brittenham
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Establishment of Secondary Iron Overloaded Mouse Model: Evaluation of Cardiac Function and Analysis According to Iron Concentration
Se Na Moon et al.
PEDIATRIC CARDIOLOGY (2011)
Real-World Use of Iron Chelators
Janet L. Kwiatkowski
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
The heart in Friedreich's Ataxia: Basic findings and clinical implications
R. Mark Payne
PROGRESS IN PEDIATRIC CARDIOLOGY (2011)
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Stefania Recalcati et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
Paolo Arosio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Two to Tango: Regulation of Mammalian Iron Metabolism
Matthias W. Hentze et al.
CELL (2010)
Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload
Xueshan Gao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Antonello Pietrangelo
GASTROENTEROLOGY (2010)
Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment
Colm J. Murphy et al.
JOURNAL OF CARDIAC FAILURE (2010)
The emerging role of iron dyshomeostasis in the mitochondrial decay of aging
Jinze Xu et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?
Vinod Pullarkat
BLOOD (2009)
History and Current Impact of Cardiac Magnetic Resonance Imaging on the Management of Iron Overload
John C. Wood
CIRCULATION (2009)
Safety and Efficacy of Combined Chelation Therapy with Deferasirox and Deferoxamine in a Gerbil Model of Iron Overload
Maya Otto-Duessel et al.
ACTA HAEMATOLOGICA (2008)
Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy
Lakshmi D. Devanur et al.
BIOCHEMICAL JOURNAL (2008)
Longitudinal analysis of heart and liver iron in thalassemia major
Leila J. Noetzli et al.
BLOOD (2008)
Heart protection by ischemic preconditioning: A novel pathway initiated by iron and mediated by ferritin
Mordechai Chevion et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications
Yang-Sung Sohn et al.
BLOOD (2008)
Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications
Maya Shvartsman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance
M. A. Tanner et al.
CIRCULATION (2007)
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1
Susanne Ludwiczek et al.
NATURE MEDICINE (2007)
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells
Juan P. Liuzzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
DJ Pennell et al.
BLOOD (2006)
Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
Gavin Y. Oudit et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model
GY Oudit et al.
CIRCULATION (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin
CJ Miranda et al.
BLOOD (2003)
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy
GY Oudit et al.
NATURE MEDICINE (2003)
Nature of nontransferrin-bound iron
RC Hider
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson et al.
EUROPEAN HEART JOURNAL (2001)
Association of age, sex, and race with body iron stores in adults: Analysis of NHANES III data
LR Zacharski et al.
AMERICAN HEART JOURNAL (2000)